| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Cansu Kücükköse, Asli Aras Taskin, Adinarayana Marada, Tilman Brummer, Sven Dennerlein, Friederike-Nora Vögtl. Functional coupling of presequence processing and degradation in human mitochondria. The FEBS journal. vol 288. issue 2. 2021-06-17. PMID:32491259. |
as the matrix presequence peptidase prep has been reported to play a role in alzheimer's disease, analysis of impaired peptide turnover in human cells is of huge interest. |
2021-06-17 |
2023-08-13 |
human |
| Xueju Zhang, Chuanbin Wu, Wen Ta. Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer's Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization-Mass Spectrometry Imaging Techniques. Journal of proteome research. vol 20. issue 5. 2021-06-17. PMID:33780243. |
brain lipid dynamics in amyloid precursor protein/presenilin 1 mouse model of early alzheimer's disease by desorption electrospray ionization and matrix assisted laser desorption ionization-mass spectrometry imaging techniques. |
2021-06-17 |
2023-08-13 |
mouse |
| Ali Aijaz Hussain, Yunhee Lee, Jin-Jun Zhang, Paul T Francis, John Marshal. Disturbed Matrix Metalloproteinase Pathway in Both Age-Related Macular Degeneration and Alzheimer's Disease. Journal of neurodegenerative diseases. vol 2017. 2021-06-16. PMID:28197357. |
disturbed matrix metalloproteinase pathway in both age-related macular degeneration and alzheimer's disease. |
2021-06-16 |
2023-08-13 |
Not clear |
| Kie Abe, Yuhei Chiba, Saki Hattori, Asuka Yoshimi, Takeshi Asami, Omi Katsuse, Akira Suda, Akitoyo Hishimot. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database. Journal of the neurological sciences. vol 416. 2021-05-14. PMID:32603972. |
influence of plasma matrix metalloproteinase levels on longitudinal changes in alzheimer's disease (ad) biomarkers and cognitive function in patients with mild cognitive impairment due to ad registered in the alzheimer's disease neuroimaging initiative database. |
2021-05-14 |
2023-08-13 |
Not clear |
| Kie Abe, Yuhei Chiba, Saki Hattori, Asuka Yoshimi, Takeshi Asami, Omi Katsuse, Akira Suda, Akitoyo Hishimot. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database. Journal of the neurological sciences. vol 416. 2021-05-14. PMID:32603972. |
the present study investigated the effects of plasma matrix metalloproteinases (mmps) on longitudinal changes in alzheimer's disease (ad)-related biomarkers in cerebrospinal fluid (csf), brain atrophy, and cognitive function in patients with mild cognitive impairment due to ad (mci-ad). |
2021-05-14 |
2023-08-13 |
Not clear |
| Masoud Hoore, Sahamoddin Khailaie, Ghazal Montaseri, Tanmay Mitra, Michael Meyer-Herman. Mathematical Model Shows How Sleep May Affect Amyloid-β Fibrillization. Biophysical journal. vol 119. issue 4. 2021-05-14. PMID:32758420. |
deposition of amyloid-β (aβ) fibers in the extracellular matrix of the brain is a ubiquitous feature associated with several neurodegenerative disorders, especially alzheimer's disease (ad). |
2021-05-14 |
2023-08-13 |
Not clear |
| Erika Hemmerová, Tomáš Špringer, Zdeňka Krištofiková, Jiří Homol. Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study. International journal of molecular sciences. vol 21. issue 24. 2021-04-09. PMID:33419257. |
in early stages of alzheimer's disease (ad), amyloid beta (aβ) accumulates in the mitochondrial matrix and interacts with mitochondrial proteins, such as cyclophilin d (cypd) and 17β-hydroxysteroid dehydrogenase 10 (17β-hsd10). |
2021-04-09 |
2023-08-13 |
Not clear |
| Rowan Pentz, M Florencia Iulita, Maya Mikutra-Cencora, Adriana Ducatenzeiler, David A Bennett, A Claudio Cuell. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology. Neurobiology of disease. vol 148. 2021-03-23. PMID:33130223. |
a new role for matrix metalloproteinase-3 in the ngf metabolic pathway: proteolysis of mature ngf and sex-specific differences in the continuum of alzheimer's pathology. |
2021-03-23 |
2023-08-13 |
rat |
| Rowan Pentz, M Florencia Iulita, Maya Mikutra-Cencora, Adriana Ducatenzeiler, David A Bennett, A Claudio Cuell. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology. Neurobiology of disease. vol 148. 2021-03-23. PMID:33130223. |
matrix metalloproteinase-3 (mmp-3) has been associated with risk of alzheimer's disease (ad). |
2021-03-23 |
2023-08-13 |
rat |
| Erik Tedesco, Federico Benetti, Raffaele Pezzan. In vitro evaluation of different organic matrices used to modulate silicon bioavailability. FASEB journal : official publication of the Federation of American Societies for Experimental Biology. vol 34. issue 9. 2021-03-16. PMID:32681588. |
it is an element of the extracellular matrix; it is involved in collagen synthesis, bone mineralization, and immune system modulation; and it reduces metal accumulation in alzheimer's disease and the risk of atherosclerosis. |
2021-03-16 |
2023-08-13 |
human |
| Lidia Ciccone, Jennifer Vandooren, Susanna Nencetti, Elisabetta Orlandin. Natural Marine and Terrestrial Compounds as Modulators of Matrix Metalloproteinases-2 (MMP-2) and MMP-9 in Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland). vol 14. issue 2. 2021-03-16. PMID:33498927. |
natural marine and terrestrial compounds as modulators of matrix metalloproteinases-2 (mmp-2) and mmp-9 in alzheimer's disease. |
2021-03-16 |
2023-08-13 |
Not clear |
| Betty M Tijms, Johan Gobom, Lianne Reus, Iris Jansen, Shengjun Hong, Valerija Dobricic, Fabian Kilpert, Mara Ten Kate, Frederik Barkhof, Magda Tsolaki, Frans R J Verhey, Julius Popp, Pablo Martinez-Lage, Rik Vandenberghe, Alberto Lleó, José Luís Molinuevo, Sebastiaan Engelborghs, Lars Bertram, Simon Lovestone, Johannes Streffer, Stephanie Vos, Isabelle Bos, Kaj Blennow, Philip Scheltens, Charlotte E Teunissen, Henrik Zetterberg, Pieter Jelle Visse. Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics. Brain : a journal of neurology. vol 143. issue 12. 2021-03-01. PMID:33439986. |
we studied whether alzheimer's disease biological subtypes can be detected in csf proteomics using the dual clustering technique non-negative matrix factorization. |
2021-03-01 |
2023-08-13 |
Not clear |
| El Sayed Helmy El Ashry, Laila Fathy Awad, Mohamed Teleb, Nihal Ahmed Ibrahim, Marwa M Abu-Serie, Mohamed Nabil Abd Al Moat. Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology. Bioorganic chemistry. vol 96. 2021-02-24. PMID:32032847. |
recently, interest in matrix metalloproteinases (mmps) -10 and -13 has been revitalized with the growing knowledge on their relevance within the mmps network and significance of their inhibition for treatment of various diseases like arthritis, cancer, atherosclerosis and alzheimer. |
2021-02-24 |
2023-08-13 |
Not clear |
| Jun Ma, Chao Ma, Jingjing Li, Yao Sun, Fangfu Ye, Kai Liu, Hongjie Zhan. Extracellular Matrix Proteins Involved in Alzheimer's Disease. Chemistry (Weinheim an der Bergstrasse, Germany). vol 26. issue 53. 2021-02-17. PMID:32207199. |
extracellular matrix proteins involved in alzheimer's disease. |
2021-02-17 |
2023-08-13 |
Not clear |
| Ali A Hussain, Yunhee Lee, John Marshal. Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease. Progress in retinal and eye research. vol 74. 2021-02-03. PMID:31473329. |
understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: age-related macular degeneration and alzheimer's disease. |
2021-02-03 |
2023-08-13 |
Not clear |
| Pauline Zipfel, Christophe Rochais, Kévin Baranger, Santiago Rivera, Patrick Dallemagn. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. Journal of medicinal chemistry. vol 63. issue 19. 2021-01-07. PMID:32459966. |
matrix metalloproteinases as new targets in alzheimer's disease: opportunities and challenges. |
2021-01-07 |
2023-08-13 |
Not clear |
| Kévin Baranger, Amandine E Bonnet, Stéphane D Girard, Jean-Michel Paumier, Laura García-González, Wejdane Elmanaa, Anne Bernard, Eliane Charrat, Delphine Stephan, Charlotte Bauer, Katrin Moschke, Stefan F Lichtenthaler, François S Roman, Frédéric Checler, Michel Khrestchatisky, Santiago River. MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking Frontiers in molecular neuroscience. vol 9. 2020-10-01. PMID:28119565. |
mt5-mmp promotes alzheimer's pathogenesis in the frontal cortex of 5xfad mice and app trafficking we previously reported that deficiency of membrane-type five matrix metalloproteinase (mt5-mmp) prevents amyloid pathology in the cortex and hippocampus of 5xfad mice, and ameliorates the functional outcome. |
2020-10-01 |
2023-08-13 |
mouse |
| Julie Bejoy, Liqing Song, Zhe Wang, Qing-Xiang Sang, Yi Zhou, Yan L. Neuroprotective Activities of Heparin, Heparinase III, and Hyaluronic Acid on the A ACS biomaterials science & engineering. vol 4. issue 8. 2020-10-01. PMID:30533518. |
the study of microenvironment of brain tissues with alzheimer's disease revealed colocalized expression of different ecm molecules such as heparan sulfate proteoglycans (hspgs), chondroitin sulfate proteoglycans (cspgs), matrix metal-loproteinases (mmps), and hyaluronic acid. |
2020-10-01 |
2023-08-13 |
Not clear |
| Omkar Gandbhir, Pazhani Sundara. 'Amytrapper', a Novel Immobilized Sepharose API Matrix, Removes Amyloid-β from Circulation Journal of Alzheimer's disease reports. vol 3. issue 1. 2020-10-01. PMID:30842995. |
'amytrapper', a novel immobilized sepharose api matrix, removes amyloid-β from circulation alzheimer's disease (ad) is the most common cause of dementia among elderly patients afflicted by neurodegenerative diseases, caused by the accumulation of amyloid-β (aβ). |
2020-10-01 |
2023-08-13 |
mouse |
| Wonseok Lee, Sang Won Lee, Gyudo Lee, Dae Sung Yoo. Atomic Force Microscopy Analysis of EPPS-Driven Degradation and Reformation of Amyloid-β Aggregates. Journal of Alzheimer's disease reports. vol 2. issue 1. 2020-09-30. PMID:30480247. |
amyloid-β (aβ) peptides can be aggregated into β-sheet rich fibrils or plaques and deposited on the extracellular matrix of brain tissues, which is a hallmark of alzheimer's disease. |
2020-09-30 |
2023-08-13 |
Not clear |